Showing results (61-70 of 171) with videos related to
Sort By:
Pageof 18
Cancer Research|August 15, 1994
Structure-activity relationships of isothiocyanates as mechanism-based inhibitors of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in A/J miceD Jiao, K I Eklind, C I Choi, et al.The Indian Journal of Medical Research|October 1, 1994
Evaluation of PCR based test for the detection of Mycobacterium tuberculosis in coded sputum specimensP Khandekar, A G Amin, P P Reddi, et al.Journal of Spinal Disorders & Techniques|May 30, 2014
Surgical anatomy of the diaphragm in the anterolateral approach to the spine: a cadaveric studyAli A Baaj, Kyriakos Papadimitriou, Anubhav G Amin, et al.Chemistry & Biology|July 29, 2006
Characterization of a specific arabinosyltransferase activity involved in mycobacterial arabinan biosynthesisShampa Khasnobis, Jian Zhang, Shiva K Angala, et al.Journal of Virology|November 1, 2016
Potent Inhibition of Human Cytomegalovirus by Modulation of Cellular SNARE Syntaxin 5Linda Cruz, Nicholas T Streck, Kevin Ferguson, et al.World Journal of Gastrointestinal Endoscopy|September 7, 2017
Correlation of abnormal histology with endoscopic findings among mycophenolate mofetil treated patientsMitchell A Izower, Merajur Rahman, Ernesto P Molmenti, et al.Journal of Carcinogenesis|February 28, 2012
Comparative metabolism of benzo[a]pyrene by human keratinocytes infected with high-risk human papillomavirus types 16 and 18 as episomal or integrated genomesNeil Trushin, Samina Alam, Karam El-Bayoumy, et al.Cancer Letters|March 1, 1990
Effect of dietary aromatic isothiocyanates fed subsequent to the administration of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone on lung tumorigenicity in miceM A Morse, J C Reinhardt, S G Amin, et al.Diabetology & Metabolic Syndrome|September 11, 2024
The relation of mTOR with diabetic complications and insulin resistance in patients with type 2 diabetes mellitusNoha G Amin, A Abdel Rahim, Kamel Rohoma, et al.International Journal of Oncology|September 15, 2021
Targeting the mTOR pathway using novel ATP‑competitive inhibitors, Torin1, Torin2 and XL388, in the treatment of glioblastomaAnubhav G Amin, Seung Won Jeong, John L Gillick, et al.Pageof 18